美国食品和药物管理局(FDA)的建议将盐酸米多君撤出市场,目前此药用于治疗低血压,但没有足够的证据能证明该药对低血压有用。关于该药上市后的证明该药物有效的证据研究尚未完成与公开。因此,美国食品药品管理局提出将 The U.S. Food and Drug Administration’s (FDA) recommendation to withdraw middlinate from the market is currently used to treat hypotension, but there is not enough evidence to prove it is useful for hypotension. After the drug is listed on the evidence that the effective evidence that the drug has not yet completed and open. Therefore, the United States Food and Drug Administration proposed